Enlivex Hoards 3 Billion Rain at 62% Discount, Pharma Pivot to Crypto Reserves

Enlivex, a cell therapy company for knee osteoarthritis, announced on Tuesday that it has raised $21 million through a debt financing agreement with New York asset management firm The Lind Partners, to purchase an additional 3 billion RAIN tokens related to the prediction market platform Rain. The deal was completed at a 62% discount (i.e., $10 million).

Deal Details: 62% Discount Entry and Strategic Extension of Options

Enlivex stated that on Sunday, it exercised its option to acquire an additional 3 billion RAIN tokens for $10 million, at a 62% discount to the market price, and extended the option to purchase more tokens until the end of December 2027.

Chairman Shai Novik said, “We are continuing to execute our prediction market funding strategy, and we are pleased that Lind has provided us with substantial capital, enabling us to continue our operational plans and acquire approximately 3 billion additional RAIN tokens.”

On the token mechanism level, the RAIN platform has a built-in 2.5% transaction fee, which automatically repurchases and burns RAIN tokens to continuously improve the token supply and demand dynamics, directly linking Enlivex’s treasury holdings value with platform trading activity.

Enlivex’s Dual-Track Strategy: Crypto Reserves and Stock Buybacks Simultaneously Advancing

Enlivex is advancing two capital allocation initiatives simultaneously:

Recent Dual-Track Capital Allocation by Enlivex

Crypto Reserve Strategy: Purchase RAIN tokens at a discount, further expanding holdings, and retain the option to buy more tokens before the end of 2027 to build a long-term reserve position at a lower average cost.

Stock Buyback Program: Approve a separate $20 million stock repurchase plan aimed at increasing shareholder value by reducing market float.

This dual-track strategy demonstrates Enlivex’s approach to both on-chain assets and traditional shareholder returns, attempting to create synergy between the crypto narrative and stock market performance.

Market reaction saw RAIN tokens rise 7% to $0.009 after the announcement, then slightly retraced to $0.0088; Enlivex stock (ENVL) closed down 0.9% at $1.10 but traded after hours up 4.5% to $1.15.

Rain Platform Fundamentals and Prediction Market Outlook

Rain operates on the Ethereum Layer-2 Arbitrum network. According to DeFiLlama, over the past seven days, Rain ranked among the top ten global prediction market platforms in terms of total value locked (TVL) and fees.

From the overall market perspective, prediction markets are projected to grow over 1,200% in trading volume from February 2025 to February 2026, reaching $23.3 billion; however, the market remains dominated by Kalshi and Polymarket, which together account for over 80% of trading volume. For Enlivex, betting on Rain is a strategy to differentiate in a rapidly growing but still concentrated market.

Frequently Asked Questions

Why is Enlivex, a pharmaceutical company, buying RAIN tokens?

Enlivex is one of many non-crypto companies using crypto assets to strengthen their balance sheets. Such strategies aim to attract a broader investor base and increase visibility in capital markets. The automatic buyback and burn mechanism of RAIN tokens also provides a potential long-term appreciation logic for its holdings.

How is the 62% discount for RAIN tokens calculated?

Enlivex purchased 3 billion RAIN tokens for $10 million, meaning the cost per token is approximately $0.0033. Compared to the recent market price of about $0.009, this represents a discount of roughly 62%.

What makes the Rain prediction market platform special?

Rain runs on Arbitrum (Ethereum Layer-2) and features a built-in 2.5% transaction fee that automatically repurchases and burns tokens, directly linking platform activity with token supply and demand. According to DeFiLlama, Rain ranked among the top ten prediction markets globally in TVL and fees over the past week.